How to Cite
Abstract
The human microbiota is a complex ecosystem of microorganisms including bacteria, viruses, archaea, and fungi that inhabit the human body. Recent studies have highlighted the importance of the microbiota in different physiological processes, including metabolism, immunity and inflammation. In the context of renal function, several studies have indicated that the microbiota may play an important role in the development and progression of chronic kidney disease (CKD). This literature review article provides a comprehensive overview of the literature that focuses primarily on the relationship between the gut microbiota and CKD, and highlights gaps in this knowledge. Recent evidence supporting the notion that the microbiota has an impact on CKD is summarized, discusses the potential mechanisms of the gut-kidney axis, and discusses the therapeutic potential of strategies targeting the gut microbiota.
Keywords
References
Sampaio-Maia B, Simões-Silva L, Pestana M, Araujo R, Soares-Silva IJ. The Role of the Gut Microbiome on Chronic Kidney Disease. Adv Appl Microbiol [Internet]. 2016 [citado 8 marzo 2023];96:65-94. DOI: 10.1016/bs.aambs.2016.06.002. Epub 2016 Jul 18. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27565581/
Wehedy E, Shatat IF, Al Khodor S. The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword. Front Med (Lausanne) [Internet]. 17 enero 2022 [citado 8 marzo 2023];8:790783. DOI: 10.3389/fmed.2021.790783. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35111779/
Plata C, Cruz C, Cervantes LG, Ramírez V. The gut microbiota and its relationship with chronic kidney disease. Int Urol Nephrol [Internet]. Diciembre 2019 [citado 8 Marzo 2023];51(12):2209-2226. DOI: 10.1007/s11255-019-02291-2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31576489/
Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, Liu W, Gao D, Wu Z, Guo S, Wu G, Liu Z, Yu Z, Li L. Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Adv Sci (Weinh) [Internet]. 2 septiembre 2020 [citado 9 marzo 2023];7(20):2001936. DOI: 10.1002/advs.202001936. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33101877/
King CH, Desai H, Sylvetsky AC, LoTempio J, Ayanyan S, Carrie J, Crandall KA, Fochtman BC, Gasparyan L, Gulzar N, Howell P, Issa N, Krampis K, Mishra L, Morizono H, Pisegna JR, Rao S, Ren Y, Simonyan V, Smith K, VedBrat S, Yao MD, Mazumder R. Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS One [Internet]. 11 septiembre 2019 [citado 9 marzo 2023];14(9):e0206484. DOI: 10.1371/journal.pone.0206484. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31509535/
Lau WL, Savoj J, Nakata MB, Vaziri ND. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond) [Internet]. 9 Mar 2018 [citado 9 marzo 2023];132(5):509-522. DOI: 10.1042/CS20171107. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29523750/
Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, Zhao YY. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med. [Internet]. 3 enero 2019 [citado 10 marzo 2023]; 17(1):5. DOI: 10.1186/s12967-018-1756-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30602367/
Rysz J, Franczyk B, Ławiński J, Olszewski R, Ciałkowska-Rysz A, Gluba-Brzózka A. The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins (Basel) [Internet]. 31 Mar 2021 [citado 10 marzo 2023];13(4):252. DOI: 10.3390/toxins13040252. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33807343/
Zhang Y, Zhou L, Xia J, Dong C, Luo X. Human Microbiome and Its Medical Applications. Front Mol Biosci [Internet]. 13 enero 2022 [citado 10 marzo 2023]; 8:703585. DOI: 10.3389/fmolb.2021.703585. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35096962/
Hsu CK, Su SC, Chang LC, Shao SC, Yang KJ, Chen CY, Chen YT, Wu IW. Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of International Studies. Int J Med Sci [Internet]. 25 octubre 2021 [citado 12 marzo 2023]; 18(16):3839-3850. DOI: 10.7150/ijms.66451. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34790060/
Lai S, Molfino A, Testorio M, Perrotta AM, Currado A, Pintus G, Pietrucci D, Unida V, La Rocca D, Biocca S, Desideri A. Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease. Nutrients [Internet]. 9 diciembre 2019 [citado 12 marzo 2023]; 11(12):3006. DOI: 10.3390/nu11123006. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950025/
Cases A, Cigarrán-Guldrís S, Mas S, Gonzalez-Parra E. Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider. Nutrients [Internet]. 4 enero 2019 [citado 12 marzo 2023]; 11(6):1263. DOI: 10.3390/nu11061263. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627351/
Carrero JJ, González-Ortiz A, Avesani CM, Bakker SJL, Bellizzi V, Chauveau P, Clase CM, Cupisti A, Espinosa-Cuevas A, Molina P, Moreau K, Piccoli GB, Post A, Sezer S, Fouque D. Plant-based diets to manage the risks and complications of chronic kidney disease. Nat Rev Nephrol. [Internet] . 16 septiembre 2020 [citado 12 marzo 2023]; 16(9):525-542. DOI: 10.1038/s41581-020-0297-2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32528189/
Cosola C, Rocchetti MT, Sabatino A, Fiaccadori E, Di Iorio BR, Gesualdo L. Microbiota issue in CKD: how promising are gut-targeted approaches? J Nephrol. [Internet]. Febrero 2019 [citado 13 marzo 2023];32(1):27-37. DOI: 10.1007/s40620-018-0516-0. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30069677/
McFarlane C, Ramos CI, Johnson DW, Campbell KL. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis. J Ren Nutr. [Internet]. Mayo 2019 [citado 13 marzo 2023];29(3):209-220. DOI: 10.1053/j.jrn.2018.08.008. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30366767/
Vacca M, Celano G, Lenucci MS, Fontana S, Forgia FM, Minervini F, Scarano A, Santino A, Dalfino G, Gesualdo L, De Angelis M. In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients. Microorganisms [Internet]. 17 enero 2021 [citado 13 marzo 2023];9(6):1316. DOI: 10.3390/microorganisms9061316. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34204263/
Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients [Internet]. 17 junio 2022 [citado 13 marzo 2023]; 14(12):2528. DOI: 10.3390/nu14122528. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35745257/
Caggiano G, Cosola C, Di Leo V, Gesualdo M, Gesualdo L. Microbiome modulation to correct uremic toxins and to preserve kidney functions. Curr Opin Nephrol Hypertens. [Internet]. Enero 2020 [citado 13 marzo 2023]; 29(1):49-56. DOI: 10.1097/MNH.0000000000000565. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31725010/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Array